9- PHARMA MULTI-C...
Follow
Find
24.1K views | +227 today
9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK
MULTI CHANNEL MARKETING IN PHARMA / MULTICANAL DANS LA PHARMA
Your new post is loading...
Your new post is loading...
Rescooped by Lionel Reichardt / le Pharmageek from e-Marketing for the healthcare sector
Scoop.it!

IMS Report highlights challenges of pharma |

IMS Report highlights challenges of pharma | | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
Despite abundant and growing amounts of data being generated and accessed by life sciences companies, analytic have not kept pace."

Via Michael Lucht - www.b-innovative.eu
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Healthcare & Social Business Solutions
Scoop.it!

IMS mHealth Report: It's an App Jungle. Will the Fittest Apps Survive?

IMS mHealth Report: It's an App Jungle. Will the Fittest Apps Survive? | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
According to the 2013 IMS mHealth report, health apps in the US number 43,000+. In such an app jungle, will patients be able to find reliable health advice?

Via Art Jones
more...
Art Jones's curator insight, March 18, 2014 12:44 AM

Excerpt: One of the problems with mHealth apps, is that very rarely are medical professionals the ones who create them. 

Beverly Morgan's curator insight, March 18, 2014 9:27 AM

"If you are a healthcare provider, you can now create your own branded patient apps. The MobileSmith platform allows you to easily and quickly build multiple mHealth apps with functions that meet both doctor and patient needs, without writing a single line of code.  Take control of your app development and ensure the survival of your apps in the mHealth app jungle!" -

Love this opportunity for healthcare systems & physicians to gain huge rewards from patient satisfaction if some of the triage and registration process was an app oN your phone. 

Rescooped by Lionel Reichardt / le Pharmageek from patient engaged
Scoop.it!

Don't Forget: FDA Frequents Facebook - Food, Drugs, Healthcare, Life Sciences - United States

Don't Forget: FDA Frequents Facebook - Food, Drugs, Healthcare, Life Sciences - United States | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
17 Mar 2014 - United States - Food, Drugs, Healthcare, Life Sciences - Don't Forget: FDA Frequents Facebook - Reed Smith - In only the second Untitled Letter of the year, FDA’s Office of Prescription Drug Promotion warned a Swiss drug company about statements the company made on its Facebook page.

Via Ginny Dillon
more...
Ginny Dillon's curator insight, March 17, 2014 4:42 PM

FDA sends warning to pharma company about lack of required information on their consumer facing FaceBook page.

Rescooped by Lionel Reichardt / le Pharmageek from Pharma Marketing
Scoop.it!

How Google’s Knowledge Graph Impacts Pharma |

How Google’s Knowledge Graph Impacts Pharma | | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
Pharma advertisers can still benefit from the Knowledge Graph placement.

Via COUCH.
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Chiffres et infographies
Scoop.it!

73% des consommateurs achèteraient après avoir regardé une vidéo - #Arobasenet

73% des consommateurs achèteraient après avoir regardé une vidéo - #Arobasenet | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
La vidéo aurait aussi un impact puissant sur la décision d'achat des consommateurs. C'est en tout cas ce que nous révèle cette étude récente.

Via Arobasenet
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Pharma Marketing
Scoop.it!

Pharma: time to take a dose of digital

Pharma: time to take a dose of digital | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
In pharmaphorum's digital and social media themed month we hear from EFPIA on pharma's use of social media and the importance of joining the increasing online conversations. Without question, the digital age is shaping the way individuals around...

Via COUCH.
more...
No comment yet.
Scooped by Lionel Reichardt / le Pharmageek
Scoop.it!

The Power to Connect Through Visual Storytelling

The Power to Connect Through Visual Storytelling | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
Given their experience managing social media for industry-leading companies,Ekaterina Walter and Jessica Gioglio were inspired to see the dramatic changes taking place across the social media landscape in favor of visual imagery and storytelling. Learn why this visual revolution is so important and what it means for the future of marketing.
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from All about Pharma by Pharmacomptoir
Scoop.it!

Pharma Summit: Rethinking the future – new business models for pharma

Pharma Summit: Rethinking the future – new business models for pharma | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
The way pharma works needs to change with an increasing focus on collaborations, sharing data and access to medicines, according to a panel discussion at The Economist’s Pharma Summit in London yesterday.

Via Pharmacomptoir / Corinne Thuderoz
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Pharma Marketing
Scoop.it!

On the COUCH #17: Is it time we change the way we think about digital pharma?

On the COUCH #17: Is it time we change the way we think about digital pharma? | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
Traditionally marketing and sales aren’t very good friends, and we’ve blogged previously about why it’s important to get them aligned and working together in the pharma industry for the benefit of the business. Here’s the good news: modern technology can go a long way towards making that possible. How so?

Via COUCH.
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Hospitals: Trends in Branding and Marketing
Scoop.it!

Healthcare Marketing: Using Video to Reach Your Audience

Healthcare Marketing: Using Video to Reach Your Audience | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
Recent statistics indicate that the use of video within a marketing strategy results in increased brand exposure and confidence. The same is true for healthcare practices, as video content is used to enhance audience ...

Via eMedToday
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Pharma: Trends and Uses Of Mobile Apps and Digital Marketing
Scoop.it!

Understanding Website Design & Online Marketing in the Pharmaceutical Industry

Understanding Website Design & Online Marketing in the Pharmaceutical Industry | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
The pharmaceutical industry is a very interesting but challenging sector. Here are some of the issues & potential solutions regarding website design and online marketing.

Via eMedToday
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Pharma Digital
Scoop.it!

5 Digital Marketing Myths #pharma

5 Digital Marketing Myths #pharma | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it

Myth #1: Digital Marketing is All About Technology


Myth #2: We Can Find One Platform That Does it All.


Myth #3: Our Mobile Audience is Small, So We Don’t Need to Invest in Our Mobile Presence.


Myth #4: Our Marketing & Communications Department is Too Small to Take on a Sophisticated Digital Marketing Program


Myth #5: Treating Your Website as a Cost Center, Instead of a Revenue Generating Asset.


Read more: http://www.business2community.com/digital-marketing/5-digital-marketing-myths-0790598#!zxuxg


Via Parag Vora
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Pharma: Trends in e-detailing
Scoop.it!

Virtual Pharma Rep(TM) to Launch First Pharmacuetical E-Detailing Campaign for the South African Market

SOURCE: Virtual Pharma Rep Virtual Pharma Rep TM Leads the Paradigm Shift to Virtual Sales in South Africa's Pharmaceutical Industry JOHANNESBURG, SOUTH (Virtual Pharma Rep(TM) to Launch First Pharmacuetical...

Via eMedToday
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Digital marketing pharma
Scoop.it!

9 ways Pharma can use visuals to boost its social media presence

9 ways Pharma can use visuals to boost its social media presence | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it

Great article from @bstormdigital on 9 ways pharma can use visuals to boost social media presence. http://t.co/XZ5llg6voj #pharmamktg


Via Olivier Delannoy
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Digital Pharma news
Scoop.it!

The gates to social media are opening for the pharmaceutical industry, but with access comes responsibility

The gates to social media are opening for the pharmaceutical industry, but with access comes responsibility | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it

Since social media was widely adopted more than five years ago, the pharmaceutical industry has tiptoed around the edges of the platform, concerned that diving in would obligate companies and brands to keep tabs on and manage all consumer-generated content. If the content is incorrect, patient outcomes and adherence could suffer; but in the absence of FDA guidance, and with limited resources, what can our industry do? Until recently, there has been little feedback from the FDA regarding our perceived responsibility as an industry. However, the draft guidance published in January 2014 titled "Fulfilling Regulatory Requirements for Postmarketing Submissions of Interactive Promotional Media for Prescription Human and Animal Drugs and Biologics" appears to address pharma's expanding role in engaging its audiences with promotional online activities, including what it can do with content after it's been approved and published.

The FDA on real-time communications and interactions

The FDA makes an important, time-saving distinction in the draft guidance related to "real-time communications and interactions (e.g., blogs, microblogs, social networking sites, online communities, and live podcasts)." Due to the long lead time of internal promotional review, it realizes it's impossible for pharmas to submit every new piece of content for review before publication. With the volume of material generated, the submission process would impede conversation and create a backlog for the reviewers.


"The FDA makes an important, time-saving distinction in the draft guidance..."



The FDA on promotional language

The FDA's draft guidance recognizes product language as promotional even it is not physically connected to a product (e.g., a label on a bottle or package) and that the contextual relationship between a product and its labeling is the key. In the digital world, this means associations are made even if an item and its descriptor do not appear next to each other. Inference has always been an important focus for the FDA in reviewing promotional items – there have been many cases where the FDA discouraged a color scheme that links branded and non-branded material.

What you're really responsible for

Next we get to the meat of the guidance: in short, if you own it, control it, create it, influence it (more about this in a minute), or operate it, then you are responsible for it. Clear, simple, specific. In prior discussions with the FDA, its representatives have been resolute on this point. If the FDA can ultimately prove that you knew about content you should be responsible for, it will insist you take responsibility for it.


"If the FDA can ultimately prove that you knew about content you should be responsible for, it will insist you take responsibility for it."



The FDA on third-party site promotion

"Under certain circumstances, a firm is responsible for promotion on third-party sites." The FDA clarifies this to be content focused: if you read and / or revise content for a digital venue, such as an advocacy resource like an organization's Facebook page before publication, then you are responsible for the content and must follow the FDA's standard procedures. Financial responsibility (such as providing a grant that enables the content to be developed) does not equate to content responsibility. This distinction is important because it means there is a growing opportunity for pharmaceutical companies to use existing healthcare communications – such as mobile health apps, health activist blogs and foundation sites – instead of building the digital venues themselves. This could be a real benefit to consumers and pharma by reaching the audience where they are already engaged and saving promotional dollars.

The FDA adds that although content submitted to these venues must be approved, how the third party uses the materials is not the pharmaceutical company's responsibility. A great example (non-digital) is one from years ago when a TV news program that was integrating approved product messaging decided to shorten the program and deleted some critical compliance information. The pharmaceutical company was not held responsible, and the current guidance reiterates the FDA's commitment to evaluate these types of circumstances independently.

The current draft guidance does state that employees or agents (vendors, agency partners) are responsible for publicly communicated product promotions. Therefore, pharmaceutical companies should clarify their internal employee social media guidelines. And, they need to take care when providing materials to health activists if there is any financial remuneration since the FDA will hold pharma companies accountable for the relationship. The FDA wants relationships clearly identified but is appearing lenient if there is no direct financially beneficial relationship with the company.

Overall, the recent draft guidance goes a long way to opening the door for pharma to participate in digital channels with user-generated content, provided there is transparency with the FDA all along the way. The draft guidance reduces many barriers to engaging in social media as a promotional vehicle, while highlighting the importance of being responsible for content you place, manage, or maintain, as well as the need for fully transparent relationships. It also puts a spotlight on the significant resources required to support the management of social media content; to many, it simply may not be worth the investment. That said, we hope to see the industry take advantage of the opportunity to develop deeper connections and support better health outcomes through these communication channels.

 


Via Plus91, Rémy TESTON
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Télémédecine
Scoop.it!

MSD France lance un site web dédié à la gale

MSD France lance un site web dédié à la gale | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
Le laboratoire MSD France a lancé il y a quelques jours un nouveau site web dédié à la gale : jaipaslagale.com. Présentation. Pour sensibiliser le grand public sur la gale et dédramatiser cette pat...

Via Isabelle Delignière-Léglise, Astelos_Sante
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Pharma: Trends and Uses Of Mobile Apps and Digital Marketing
Scoop.it!

Glaxo to Bring Doctors In-House as Speakers in Marketing Reform

Glaxo to Bring Doctors In-House as Speakers in Marketing Reform
Bloomberg
The experts will also be expected to use a growing range of digital tools designed to help market products, Connelly said.

Via eMedToday
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Personal Branding and Professional networks - @TOOLS_BOX_INC @TOOLS_BOX_EUR @TOOLS_BOX_DEV @TOOLS_BOX_FR @TOOLS_BOX_FR @P_TREBAUL @Best_OfTweets
Scoop.it!

Social Media Life Cycle - Social Media Center |

Social Media Life Cycle - Social Media Center | | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
The Social Media Life Cycle describes the processes and stimuli involved in transforming attention into affection, creating social commerce in full motion.

Via Philippe Trebaul
more...
Heather Koroll's curator insight, March 15, 2014 8:28 PM

add your insight...

 
commentrix's curator insight, March 16, 2014 4:05 AM

The Social Media Life Cycle: A Clear Description!

Scooped by Lionel Reichardt / le Pharmageek
Scoop.it!

AstraZeneca now led by science, not commercial milestones, says R&D head

AstraZeneca now led by science, not commercial milestones, says R&D head | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
AstraZeneca has turned its back on a commercially-led approach in favour of a 'science first' strategy, according to its head of drug development. Mene Pangalos, AstraZeneca's executive vice-president of Innovative Medicines and Early Development...
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from [Pharma & Life sciences: patient-centricity, social media and direct communication to patients - Pharma multichannel communication & marketing - Personalised medicine - Digital drug products] by VAB Traductions
Scoop.it!

Forbes Health Critical Cegedim March 2014 - YouTube


Via VAB Traductions
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Social Media and Healthcare
Scoop.it!

Why Doctors need Digital Marketing

Why Doctors need Digital Marketing | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
Infographic: Digital marketing techniques for gaining patient leads, building brand presence and maintaining doctor's reputation, and patient relationships.

Via Plus91
more...
No comment yet.
Scooped by Lionel Reichardt / le Pharmageek
Scoop.it!

DIGITAL DISTRESS What Keeps Marketers Up at Night?

82% digital marketers learn on the job with no formal training http://t.co/dKdHtyEnzX Great read for #hcsm folks http://t.co/ZCZXoL8i2l
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Pharma: Trends and Uses Of Mobile Apps and Digital Marketing
Scoop.it!

eMail can drive pharma brand objectives

eMail can drive pharma brand objectives | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
POST SUMMARY: According to Forbes a recent study by predictive analytics firm Custora discovered that customer acquisition via email has quadrupled in the last four years and now accounts for almost...

Via eMedToday
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Pharma: Trends in e-detailing
Scoop.it!

The Evolution of E-detailing & the Interactive Visaid

The Evolution of E-detailing & the Interactive Visaid | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
Use your next interactive visaid to get to know your customer with dynamic charts and graphs, survey, tracking and metrics.

Via eMedToday
more...
Dr Maruthi Viswanathan's curator insight, March 16, 2014 11:49 AM

In Pharma digital strategy, physician engagement, sales-force excellence and patient education/adherence have always been the key focus area. Technology is growing at an exponential rate and like other industries, even Pharma industry needs to leverage the advantage of the cutting edge technology like augmented reality, virtual reality, virtual 3D simulations, R-Detail, virtual training solutions and more.

The solutions based on these technologies are found to be promising in reaching the target audience, interacting with rich content and engage them to meet the program objectives within a short span of time.

Click the link below to take a quick tour of the next generation mobility technology available for the Pharma industry from RxLab – An innovative digital engagement research laboratory of RxPrism Health Systems.

http://youtu.be/SzjLWpq3ahY ;


To know more about Pharma and Healthcare related next generation digital solutions, kindly reply to this email or write tohello@rprism.com